by Jordana Choucair | May 18, 2022 | Life Sciences
House Appropriations Committee Chairwoman Rosa DeLauro filed supplemental funding legislation to address the nationwide baby formula shortage. The legislation would give the FDA $28 million in emergency funds to address the shortage and prevents future shortages. The...
by Jordana Choucair | May 18, 2022 | Life Sciences
Senate HELP Committee Chair Patty Murray and Ranking Member Richard Burr introduced a plan that would bolster FDA oversight of dietary supplements, cosmetics, and lab-developed tests. The proposal would require premarket approval of supplements, make manufacturers...
by Jordana Choucair | May 18, 2022 | M&A
New Jersey regulators approved RWJBarnabas Health’s and Saint Peter’s Healthcare System’s proposed integration plan. The two health systems had signed a definitive agreement declaring their “intention to integrate” in late 2020. They are now awaiting a final approval...
by Jordana Choucair | May 17, 2022 | Access & Coverage
The Congressional Budget Office (CBO) released a brief projecting that lowering Medicare coverage to Americans over 60 would add about 7.3 million people to the program and cost $155 billion over a five-year period. Lowering the eligibility age would result in about...
by Jordana Choucair | May 17, 2022 | Life Sciences
Twenty-four states filed a legal brief supporting the federal government’s battle against six drugmakers over 340B restrictions. The states said that the drugmakers – AstraZeneca, Eli Lilly, Novartis, Novo Nordisk, Sanofi, and United Therapeutics – unlawfully cut off...
Recent Comments